About: Psoriatic arthritis

Documentation

scienceplus.abes.fr version Bêta

scienceplus.abes.fr | explorer

À propos de : Psoriatic arthritis Goto Sponge NotDistinct Permalink

Attributs	Valeurs
type	Concept
rdfs:label	Psoriatic arthritis
skos:inScheme	http://hub.abes.fr/referentiel/bmjarticlecategories
is Subject of	SAT0312 Psoriasis and psoriatic arthritis among natives and mestizos from the andean mountains region of peru SAT0309 Serum 14-3-3 ETA: An independent biomarker associated with joint damage in psoriatic arthritis AB0584 Safety and efficacy of etanercept in patients with active psoriatic arthritis with peripheral involvement in belgium: 66 months follow-up. SAT0290 Higher Prevalence of Cardiovascular Risk Factors Among Patients with Psoriatic Arthritis AB0589 Subclinical atherosclerosis found both in psoriatic arthritis and rheumatoid arthritis SAT0303 Discrepancies in the definition of inflammatory articular disease to determine the prevalence of psoriatic arthritis after applying caspar criteria in patients with cutaneous psoriasis SAT0295 Comparison of subclinical carotid atherosclerosis in patients with psoriatic arthritis, psoriasis alone and controls SAT0302 Spinal involvement in axial psoriatic artritis is not determined by the presence of HLA-B27. Is the HLA-B27 arm of the axial SPA criteria reliable for classifying axial psoriatic arthritis? AB0930 DAREA/DAPSA (disease activity score for reactive arthritis/disease activity index for psoriatic arthritis) and related variables in patients with psoriatic arthritis (PSA) SAT0284 In Early PSA, the Ultrasonography of Hands and Wrists Synovitis and Digital soft Tissue Involvement Is More Sensitive Than Traditional Clinical Examination SAT0306 Prevalence of Subclinical Axial Inflammation in Skin Psoriasis by Whole-Body MRI AB0577 Bone mineral density in patients with psoraitic arthitis-a case control study SAT0297 Comparison of Composite Disease Activity Scores in Psoriatic Arthritis SAT0308 Efficacy and toxicity of leflunomide monotherapy versus leflunomide combination therapy with non-biological disease-modifying antirheumatic drugs in psoriatic arthritis SAT0292 Clinical and Patient-Reported Outcome Measures as Predictors of Poor Functional Outcome in Psoriatic Arthritis AB0923 Subclinical entheseal involvement in patients with psoriasis: A case-control ultrasound study AB0940 Cross-sectional prevalence of malignancy in a cohort of patients with psoriatic arthritis AB0948 Disease duration is a factor of the joint damage in DMARDs naÏve early perypheral psoriatic arthritis patients SAT0277 Clinical Response in Early Psoriatic Arthritis may be Predicted by Rapid Reduction of a Semiquantitative Ultrasound Synovitis Score AB0578 Anti-tnfa therapy in psoriatic arthritis: different rate of remission in polyarticular and oligoarticular subsets AB0933 Uveitis is associated with increased arterial stiffness and subclinical atherosclerosis in patients with psoriatic arthritis SAT0291 Reduced joint counts misclassify PSA patients with oligoarthritis and miss significant active disease AB0924 Psychological distress symptoms and illness perceptions associated with health-related quality of life in psoriatic arthritis patients SAT0301 A comparative analysis of PSA spondylitis patients with PSA and AS 12 months after initiation of TNFI therapy AB0949 Treatment in mono-/oligo- and polyarthritic patients; a study on the swedish early psoriatic arthritis cohort (SWEPSA) SAT0263 Biologic Therapy, Time to Low Disease Activity, and Effect of Mono Vs. Background Oral Dmard Therapy Among Psoriatic Arthritis Patients in a US Registry. SAT0287 Long-Term Safety Of Ustekinumab: 5 Years of Follow-Up from the Psoriasis Clinical Development Program Including Patients with Psoriatic Arthritis SAT0276 Improvements in Productivity at Paid Work and Within Household, and Increased Participation in Daily Activities After 24 Weeks of Certolizumab Pegol in Patients with Psoriatic Arthritis: Results of Rapid-PSA Study AB0579 The relationship between visceral adiposity index and disability function in a cohort of psoriatic arthritis patients AB0926 The relationship between disease activity indices in patients with psoriatic arthritis AB0934 Higher disease activity and earlier arthritis onset are associated with risk of coronary heart disease development in patients with psoriatic arthritis AB0925 Enthesis ultrasound in patients with psoriatic sponylarthritis AB0947 Musculoskeletal surgery in early (below 3 years of disease onset) spondyloarthritis is reported predominantly by caucasian, male, psoriatic arthritis patients among patients with spondyloarthritis SAT0280 Efficacy of Apremilast, An Oral Phosphodiesterase 4 Inhibitor, on Physical Function and Pain in Patients with Psoriatic Arthritis, Including Current Skin Involvement: Results of a Phase 3, Randomized, Controlled Trial SAT0298 Effect of Certolizumab Pegol on Signs and Symptoms in Patients with Psoriatic Arthritis from the Rapid-PSA Study: Impact of Baseline Skin Involvement and Prior Anti-TNF Therapy SAT0265 Distilling Key Elements of Existing Questionnaires to Create a New Screening Tool for Psoriatic Arthritis AB0582 Traditional cardiovascular risk factors in psoriatic arthropathy. association with cardiovascular events. SAT0287 High prevalence of articular involvement in patients with severe psoriasis with poor performance of screening questionnaires SAT0299 Morphometric X-ray absorptiometry in the assessment of vertebral fractures in patients with psoriatic arthritis and their relationship to disease activity and functional ability AB0945 Effect of adalimumab treatment of psoriatic arthritis patients (PSA) on galactosylation of serum IGG. A preliminary report AB0946 Anti-TNF treated psoriatic arthritis: Course of composite disease activity measures and clinical core domains SAT0266 Obesity is Associated with Lower Probability of Achieving Sustained Minimal Disease Activity State Among Patients with Psoriatic Arthritis SAT0275 High Economic Burden of Moderate to Severe Psoriatic Arthritis on Paid Work and Household Productivity: Baseline Results from the Rapid-Psa Study SAT0272 Serum Ctx-I Predicts Systemic Bone Loss at the Hip Over 1 Year in Patients with Early Psoriatic Arthritis AB0573 The immunogenicity of biological therapies correlates with clinical efficacy in psoriatic arthritis (psa) in long-term treatment with infliximab and adalimumab. SAT0311 Men and women with psoriatic arthritis express a different genetic profile within the major histocompatibility complex region AB0941 Clinical characteristics of an early psoriatic arthritis cohort compared to an early rheumatoid arthritis cohort SAT0302 Clinical and Laboratory Features of Late-Onset Psoriatic Arthritis in Comparison with Younger-Onset Disease: Data from an Early Arthritis Cohort SAT0282 Presentation Patterns in a Cohort of Patients with Psoriatic Arthritis SAT0285 Progranulin-Neutralizing Autoantibodies in Psoriatic Arthritis AB0575 Prevalence of hla-cw * 06 and * 07 and its relationship with psoriatic arthritis in northwestern spain. SAT0304 Long-Term Costs of Biologics in the Treatment of Psoriatic Arthritis in the United States SAT0303 The Effect of Smoking on Treatment Response and Drug Survival in Psoriatic Arthritis Patients Treated with their First Anti-Tnf-A Drug: A Single-Centre Retrospective Analysis. AB0572 Additional risk for cardiovascular comorbidities in patients with psoriatic arthropathy SAT0314 The role of musculoskeletal us as an outcome measure in the diagnosis and management of early psoriatic arthritis AB0937 Prevalence of psoriatic arthritis in psoriasis patients according to new classification criteria AB0927 Annual golimumab utilization and costs for psoriatic arthritis patients in united states managed care plans SAT0293 Comparison of european score and two national guidelines calibrated for cardiovascular risk assessment in patients with psoriatic arthritis SAT0306 Radiographic changes in patients with early psoriatic arthritis SAT0278 Left Ventricular Dysfunction Assessed by Speckle-Tracking Strain Analysis in Patients With Psoriatic Arthritis Patients without Clinical Evidence of Cardiovascular Disease SAT0294 Patterns, Prevalence and Different Clinical Associations of Radiographic Sacroiliitis in a Large Cohort of Established Psoriatic Arthritis SAT0274 Peripheral Artery Disease in Psoriatic Arthritis: Overlooked? SAT0264 Ustekinumab Improves Physical Function, Quality of Life and Work Productivity of Patients With Active Psoriatic Arthritis who were NaÏVe To MTX, Despite MTX Therapy or Previously Treated with Anti-Tnfॅ: Results from Psummit I and Psummit II SAT0304 Comparison of sacroiliac MRI evaluation versus sacroiliac X-rays in peripheral psoriatic arthritis: Evidence of silent disease SAT0290 Effect of tnf antagonists on radiographic progression in psoriatic arthritis: Systematic review and meta-analysis of randomized controlled trials AB0936 The effect of the severity of psoriasis on screening for latent tuberculosis: A comparison study between psoriasis and rheumatoid arthritis patients SAT0300 Nail psoriasis per se does not predict psoriatic arthritis: Analysis of risk factors in a cohort of italian psoriatic patients SAT0310 The effect of dactylitis and enthesitis on disease burden in patients with psoriatic arthritis in the corrona registry SAT0296 Comparison of Clinical Cut-Offs For Diagnosis of Psoriatic Arthritis in Psoriasis Patients in European/North American Dermatology Clinics TNFα therapy in psoriatic arthritis and psoriasis AB0943 Short-term ultrasound multi-target monitoring of anti-TNF alpha treatment in patients with psoriatic arthritis AB0942 Efficacy and safety of subcutaneous anti-TNF alpha, etanercept and adalimumab, in elderly patients affected by psoriasis and psoriatic arthritis: An observational long term study AB0935 Metabolic syndrome in PSA patients is not associated with disease activity SAT0294 Monitoring disease activity in early psoriatic arthritis with ultrasound - comparison of clinical responders and nonresponders AB0587 Is health-related quality of life of patients with psoriatic arthritis worse than that of patients with psoriasis alone? SAT0299 Apremilast: Pooled Safety Analysis of Three Phase 3, Randomized, Controlled Trials in patients with Psoriatic Arthritis SAT0260 Effect of Certolizumab Pegol on the Multiple Facets of Psoriatic Arthritis as Reported by Patients with and without Prior Anti-Tnf Exposure: 24-Week Patient-Reported Outcome Results of Rapid-PSA Study AB0944 Baseline serum 14-3-3 ETA levels predict ACR50 response to adalimumab therapy in psoriatic arthritis SAT0305 MDA criteria for PSA show good correlation with physician and patient opinions and with proposed composite measures SAT0289 Impact of Psoriatic Arthritis (PSA) On Health Care Utilization (HCU) and Quality of Life (Qol) SAT0305 Costs of Best Supportive Care in the Treatment of Moderate-To-Severe Psoriatic Arthritis in the United States SAT0281 Impact of Imputation Methodology on Radiographic Progression Outcomes in the Rapid-Psa Study Of Certolizumab Pegol In Patients With Psoriatic Arthritis SAT0297 Two-year direct healthcare cost burden of psoriatic arthritis in the united states: A retrospective case study of golimumab patients SAT0301 Prevalence of Psoriatic Arthritis in a Large Cohort of Brazilian Psoriatic Patients SAT0300 Significance of Association between HLA-C*06 and Psoriatic Arthritis. A Preliminary Report. AB0929 Differences regarding the amount and frequency of alcohol intake and smoking between european and non-european patients living in the same environment and suffering from spondylarthritis according to the ASAS criteria (axial, peripheral or both) SAT0292 Facilitating a modular approach to the assessment of psoriatic arthritis SAT0289 Mri assessment of spinal involvement in psoriatic arthritis: Extent of disease relates to HLA-B27 SAT0279 Use of a Calibrated Score Chart for Cardiovascular Risk Assessment in Patients with Psoriatic Arthritis, Psoriasis Alone and Controls: Related Variables and Correlation with Carotid Ultrasound AB0576 The frequency of autoimmune thyroid disorders in patients with psoriatic arthritis and the effect of anti tnf-alpha treatment on autoimmune thyroid disease. AB0574 Prevalence of hla-drb1 in psoriatic arthritis, psoriasis and rheumatoid arthritis: comparison with healthy controls. SAT0308 Responsiveness of Patient Reported Outcomes to Biological Treatment in Psoriatic Arthritis SAT0286 Serum Immunoglobulin Free Light Chain Assessment in Psoriatic Arthritis SAT0313 The link between enthesitis and arthritis in psoriatic arthritis: A switch to a vascular phenotype at insertions may play a role in arthritis development AB0939 Anti TNF therapy and malignancy in psoriatic arthritis and ankylosing spondylitis: The biosparegister SAT0270 5 Year Safety, Efficacy, and Radiographic Data in Patients with Active Psoriatic Arthritis Treated with Golimumab: Long-Term Extension Results of the Randomized, Placebo-Controlled Study Go-Reveal SAT0261 Which Conventional DMARD to Select in the Treatment of Psoriatic Arthritis (PSA)? Data From Nor-Dmard on 1351 Treatment Courses with Methotrexate (MTX), Sulfasalazine (SSZ) And Leflunomide (LEF)

Alternative Linked Data Documents: ODE Content Formats:

RDF

ODATA

Microdata